I don't dispute the evidence the Mastitis is a $50 billion dollar global problem. The key question is what revenue POH can realistically expect to generate?
Anyone that has followed bio companies know they all engage in the the 'it's a xx billion dollar market' game, but the revenue available to them is only a fraction of that "potential" What do people think POH can generate in its first year (Sep 11 - Sep 12)? I doubt they could do more than $1m at best.
- Forums
- ASX - By Stock
- AVE
- it`s the balance sheet stupid
it`s the balance sheet stupid, page-47
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $135 | 45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
51 | 92218918 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 76402411 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
51 | 92218918 | 0.002 |
18 | 77595009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 76402411 | 24 |
0.004 | 17087707 | 16 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |